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Ultrasound-Guided Fenestration of
Tendons About the Hip and Pelvis
Clinical Outcomes
ne cause of chronic pain of the hip and pelvis may be
tendinopathy, due to tendon degeneration and a possible
tendon tear.1,2 Noninvasive treatments for such conditions
may include rest, physical therapy with an emphasis on eccentric
strengthening, and nonsteroidal anti-inflammatory drugs.3 Percuta-
neous interventional treatments are often considered, which include
corticosteroid injection, tendon fenestration, and autologous blood
injection, to name a few.4
Since the predominant histologic finding with tendinopathy is
tendon degeneration and not inflammation, intratendinous corti-
costeroid injection is typically not indicated; in addition, such
injections predispose to tendon rupture.5 Corticosteroid injection
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ORIGINAL RESEARCH
Objectives—Percutaneous ultrasound-guided needle fenestration has been used to treat
tendinopathy of the elbow, knee, and ankle with promising results. The purpose of this
study was to evaluate the clinical outcome of ultrasound-guided fenestration of tendons
about the hip and pelvis.
Methods—After Institutional Review Board approval, a retrospective search of imaging
reports from January 1, 2005, to June 30, 2011, was completed to identify patients
treated with ultrasound-guided tendon fenestration about the hip or pelvis. Subsequent
clinic notes were retrospectively reviewed to determine whether the patient showed
marked improvement, some improvement, no change, or worsening symptoms.
Results—The study group consisted of 22 tendons in 21 patients with an average age
of 55.8 years (range, 26.7–77.0 years). The treated tendons included 11 gluteus medius
(9 tendinosis and 2 partial tears), 2 gluteus minimus (both tendinosis), 8 hamstring
(6 tendinosis and 2 partial tears), and 1 tensor fascia latae (tendinosis). The average
interval to clinical follow-up was 70 days (range, 7–813 days). There was marked
improvement in 45.5% (10 of 22), some improvement in 36.4% (8 of 22), no change
in symptoms in 9.1% (2 of 22), and worsening symptoms in 9.1% (2 of 22). There were
no patient variables (age, chronicity of symptoms, sex, tendon, tendinosis versus tear,
prior physical therapy, and prior corticosteroid injection) that were significantly different
between patients who improved and those who did not. There were no cases of a sub-
sequent tendon tear or infection.
Conclusions—Clinical follow-up after ultrasound-guided fenestration of the gluteus
medius, gluteus minimus, proximal hamstring, and tensor fascia latae tendons showed
that 82% of patients had improvement in their symptoms.
Key Words—fenestration; musculoskeletal ultrasound; tendinopathy; tendinosis;
tendon; tenotomy 
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superficial to tendinosis has been shown to reduce pain,
although the effects are short lived.5 Therefore, tendon fen-
estration has been considered as a potential treatment
option for tendinopathy.
Percutaneous tendon fenestration, also called teno-
tomy or dry needling, has been used to successfully treat
tendinopathy.4 Passing a needle through an area of tendi-
nosis theoretically promotes healing through bleeding and
inflammation, which results in an increase in local growth
factors and other substances.4 The most common tendons
that have been treated with ultrasound-guided fenestration
described in the literature include the common exten-
sor tendon at the elbow, the patellar tendon, and the
Achilles tendon.6,7 There have been only limited reports
that described the use of tendon fenestration beyond these
tendons; the effectiveness of fenestration in tendons such
as those about the hip and pelvis is unknown.6
In our clinical experience, we have been asked to fen-
estrate various tendons about the body using ultrasound
guidance. The purpose of this study was to retrospectively
determine the effectiveness of ultrasound-guided tendon
fenestration about the hip and pelvis.
Materials and Methods
After Institutional Review Board approval was obtained,
with informed consent waived, the computerized radiol-
ogy information system was searched from January 1,
2005, to June 30, 2011, using key words “fenestration,”
“tenotomy,” and “dry needling.” Consecutive patients were
included if they had a percutaneous ultrasound-guided
tendon fenestration of a tendon about the hip or pelvis.
Patients’ medical records were reviewed, which included
subsequent clinic visits to determine whether the symptoms
referable to the treated tendon showed marked improve-
ment, some improvement, no change, or worsening symp-
toms compared to symptoms before the procedure. For a
symptom to be categorized as “marked improvement,” the
dictated clinical report by the referring physician had to
have included terms such as “no pain,” “complete resolu-
tion,” and “significant improvement.” All other symptom
descriptions of improvement were categorized as “some
improvement.” Patients without any clinical follow-up
were excluded.
Ultrasound-guided tendon fenestration was requested
by the referring physician as part of routine patient care
performed by 1 of 10 fellowship-trained musculoskeletal
radiologists with ultrasound and ultrasound-guided pro-
cedural experience (range 5–15 years). One of several
commercially available ultrasound machines was used
(HDI 5000 and iU22, Philips Healthcare, Bothell, WA;
and LOGIQ 9 and E9, GE Healthcare, Milwaukee, WI),
including both linear and curvilinear transducers. Although
the exact details of each patient’s procedure were inher-
ently variable given the number of radiologists and the ret-
rospective nature of this study, the following section
summarizes the general ultrasound- guided tendon fen-
estration procedure performed as part of the study. 
Fenestration Procedure
Before the procedure, all patients had avoided nonsteroidal
anti-inflammatory medication, including aspirin, for at
least 2 weeks so as not to interfere with the inflammatory
phase of early tissue healing. The abnormal tendon was
confirmed with ultrasound imaging as a target for fenes-
tration. Tendinosis was characterized as abnormal tendon
hypoechogenicity; well-defined anechoic clefts or defects
were characterized as partial tendon tears. The presence of
a full-thickness tear was a contraindication for tendon
fenestration.
With a sterile technique and a 1% lidocaine local anes-
thetic, a spinal needle (20 or 22 gauge) was advanced into
the abnormal tendon segment in plane with the ultrasound
transducer and sound beam. The needle orientation was
either long axis or short axis to the tendon at the operator’s
discretion but was typically long axis. Lidocaine injection
at the surface of the tendon was also at the discretion of the
radiologist if needed to reduce symptoms, although direct
intratendinous injection was avoided unless deemed
necessary. With the inner trocar (or stylet) removed, the
needle was repeatedly passed through the abnormal
tendon segment. The number of passes through the ten-
don varied depending on the size of the tendon abnor-
mality, although 20 to 40 passes were typical. Softening of
the abnormal tendon after treatment was considered an
additional indicator of adequate fenestration. The trans-
ducer was turned 90° and the needle repositioned as nec-
essary to ensure that the entire tendon abnormality was
treated. Additional goals included targeting the adjacent
bone as well as attempting to break up any intratendinous
degenerative calcification, which appears linear unlike the
amorphous appearance of hydroxyapatite crystal deposi-
tion. After the procedure, the patient was counseled to con-
tinue activities of daily living but to avoid strenuous activity
related to the pelvis and hip for 2 weeks and any activity that
caused pain. The patient was advised to refrain from non-
steroidal anti-inflammatory medication and ice for 2 weeks
after the procedure.
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Data Analysis
Patients’ results were evaluated to determine whether there
were any significant differences among the various clinical
outcomes. Patients were categorized into 2 groups (marked
improvement versus other outcome) and compared with
respect to demographics (age and sex), site and type of ten-
don abnormality (tendinosis or tear), chronicity of symp-
toms, and prior physical therapy or steroid injection, using
a Wilcoxon rank sum test (because the continuous vari-
ables are not normally distributed) for continuous variables
and Fisher exact test for categorical variables. Similarly,
patients were categorized into 2 groups (any improvement
versus other outcome) and compared. A 5% level of sig-
nificance was used to evaluate statistical significance in all
analyses. The above analyses were performed with SAS
version 9.4 software (SAS Institute Inc, Cary, NC).
Results
The initial retrospective search yielded 27 patients; how-
ever, 6 patients were lost to follow-up. The final study group
consisted of 22 tendon fenestrations in 21 patients (1 patient
had each hip treated) with an average age of 55.8 years
(range, 26.6–77.0 years; 16 female and 5 male). Patient
symptoms were present an average of 29 months (range,
3.2–105.8 months) before fenestration. Physical therapy
was prescribed in 45.5% (10 of 22), and prior blind corti-
costeroid injection (>6 months before fenestration) was
completed in 36.4% (8 of 22: 7 gluteal and 1 hamstring).
The tendons that were treated with fenestration
included the gluteus medius in 50% (11 of 22: 9 tendinosis
and 2 partial tears) (Figure 1), proximal hamstring in 36.4%
(8 of 22: 6 tendinosis and 2 partial tears) (Figure 2),
gluteus minimus in 9.1% (2 of 22: both tendinosis)
(Figure 3), and tensor fascia latae in 4.6% (1 of 22: tendi-
nosis) (Figure 4). Two patients had total hip arthroplasty
(both gluteus medius tendinosis). Two patients had calci-
fication within tendinosis (both proximal hamstring).
No patients had bursal distention about the greater
trochanter when evaluated with ultrasound. All patients tol-
erated the procedure without any immediate complications.
The average interval to retrospective clinical follow-
up was 70 days (SD, 168.5 days; range, 7–813 days).
Overall, there was marked improvement in 45.5% (10 of
22: 5 gluteus medius, 2 gluteus minimus, 2 hamstring, and
1 tensor fascia latae). Some improvement was seen in 36.4%
(8 of 22: 5 hamstring and 3 gluteus medius). No change
in symptoms was seen in 9.1% (2 of 22: 2 gluteus medius),
and worsening symptoms were seen in 9.1% (2 of 22: 1
gluteus medius and 1 hamstring).
When categorizing the patients into 2 groups (marked
improvement versus other outcome), there was no signif-
icant difference with regard to age (P = .63), sex (P = .35),
tendon abnormality (P = .59), specific tendon (P = .17),
chronicity of symptoms (P = .32), prior physical therapy
(P > .99), or prior corticosteroid injection (P = .67).
Similarly, when the patients were categorized into 2 groups
(any improvement versus other outcome), there was no
significant difference with regard to age (P = .43), sex
(P > .99), tendon abnormality (P = .55), specific tendon
(P = .79), chronicity of symptoms (P = .43), prior physical
therapy (P > .99), or prior corticosteroid injection (P = .60).
J Ultrasound Med 2015; 34:2029–2035 2031
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Figure 1.  Images from a 71-year-old woman with gluteus medius tendi-
nosis and fenestration. A, Sonogram in a long-axis orientation to the
gluteus medius showing abnormal hypoechoic enlargement of the glu-
teus medius tendon (arrows) at the superoposterior facet of the greater
trochanter (GT). B, Twenty-gauge needle (arrowheads) during fenes-
tration (left side of image is cephalad). 
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A more long-term assessment of patient symptoms
was then completed. Retrospective chart review identified
follow-up visits in 20 of the 21 patients, with an average
interval of 42 months (range, 1–70 months). Of the 10
patients who initially showed marked improvement in
symptoms after fenestration, clinic notes showed that 3
were asymptomatic. The remaining 7 patients received
routine clinical care (health maintenance visits) with no
description of hip symptoms or abnormal physical exami-
nation findings. Of the 8 patients with some improvement
after fenestration, follow-up visits revealed that 2 were
asymptomatic; 2 showed no change from earlier assessment
with some improvement; and 4 had notes without any
description of abnormal hip or pelvis signs or symptoms.
Of the 2 patients who had no change in symptoms after
the fenestration, 1 had an interval hip replacement and was
pain free, and the other had clinic notes without mention
of abnormal hip or pelvis signs or symptoms. Of the 2
patients who were initially worse after the fenestration,
both had been seen for routine health maintenance with no
mention made of hip or pelvis signs or symptoms. In no case
was a tendon tear or infection described or documented in
the clinical notes. The completion of physical therapy or
other exercise programs after fenestration could not be
determined given the retrospective design of this study.
Discussion
Prior research has shown that ultrasound-guided tendon
fenestration can be an effective treatment for tendinopathy.
In particular, prior studies have focused primarily on the
common extensor tendon of the elbow, the proximal patel-
lar tendon, and the Achilles tendon.6 The results of this ret-
rospective study show that ultrasound-guided tendon
fenestration can be effective in the treatment of tendinopa-
thy about the hip and pelvis, showing clinical improvement
in 82%.
The histologic findings of chronic tendinopathy have
been shown to predominantly represent an underlying
degenerative process (termed tendinosis), which includes
mucoid degeneration, angiofibroblastic proliferation, and
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Figure 2. Images from a 60-year-old woman with proximal hamstring
tendinosis and fenestration. A, Sonogram in a long-axis orientation to
the proximal hamstrings showing hamstring tendons (H) with abnormal
hypoechoic enlargement (arrows) at the ischial tuberosity (I) (right side
of image is caudal). B, Sonogram in a short-axis orientation to the ham-
strings showing a 20-gauge needle (arrowheads) with the distal tip in
the tendon (left side of image is lateral).
Figure 3. Image from a 47-year-old man with gluteus minimus tendinosis
and fenestration. Sonogram in a long-axis orientation to the gluteus
minimus showing a 20-gauge needle (arrowheads) during fenestration
with the distal tip in the abnormal hypoechoic and thickened gluteus
minimus tendon at the anterior facet of the greater trochanter (GT) (left
side of image is cephalad). 
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chondroid metaplasia.8–13 Interstitial and partial tendon
tearing may also be a feature. Given the lack of a substantial
inflammatory component, the term “tendinitis” is there-
fore not appropriate. Although inflammation does occur
acutely after an injury, inflammation decreases by 10 days
as the proliferative phase of healing begins and then becomes
absent with chronic tendinopathy.14 Describing a condi-
tion by its correct term is important when considering
appropriate tendon treatment.
Corticosteroid injection, either superficial to or within
a tendon, has previously been considered as a treatment
for chronic tendinopathy, largely because of a misunder-
standing of the underlying tendon abnormality and the
incorrect term “tendinitis” in this situation.5 The use of cor-
ticosteroid injection as an anti-inflammatory agent is ques-
tioned, as inflammation in chronic tendinopathy is not a
prominent feature. Injection of a corticosteroid superficial
to tendinosis may have merit in some situations to provide
temporary pain relief.5 Although the exact mechanism of
pain relief is controversial, such temporary pain relief may
allow the patient to complete eccentric strengthening as a
noninvasive treatment for chronic tendinopathy. Of note,
symptoms are expected to return after corticosteroid injec-
tion, and in the case of the common extensor tendon of 
the elbow, the pain will likely be more severe than before the
injection.5,15 Given the questionable use and only temporary
effects of corticosteroid injection, other percutaneous ten-
don treatments have been explored. In addition, McShane
et al16 have shown that the addition of corticosteroid injec-
tion in conjunction with ultrasound-guided tenotomy did
not improve patient outcomes. In our study, there was no
significant difference in patient outcomes after tendon fen-
estration when patients had prior corticosteroid injection.
Tendon fenestration, also termed tenotomy or dry
needling, has been used for nearly 2 decades.7 The use of
ultrasound in conjunction with tendon fenestration has the
benefits of accurately guiding the needle to the abnormal
tendon segment for treatment. The goal of tendon fenes-
tration is to convert a chronic tendon abnormality into an
acute condition to allow improved healing.4 The abnormal
area of the tendon is targeted with the needle, causing ten-
don trauma, bleeding, and a subsequent increase in local
growth factors and other substances to promote healing.4
These local changes cause inflammation of the tendon,
which is the initial phase of tissue healing, lasting up to 7 to
10 days after the procedure.14 This factor is the reason why
anti-inflammatory medications and ice are avoided during
this initial recovery period, so that the healing cascade is not
potentially dampened. The next several weeks constitute
the period of tissue proliferation, in which excessive stress
on the tendon is avoided.14 Although these postprocedural
guidelines have not been proven essential in the literature,
it is believed that following such guidelines will allow the
best chance for tissue healing.
One of the first descriptions of ultrasound-guided
tenotomy was its use for treatment of Achilles tendinopa-
thy as an alternative to surgery after failure of conservative
management.17,18 Ultrasound-guided tenotomy of the
common extensor tendon of the elbow has also been
reported.7 These results showed that the procedure was
safe and effective, with 85.5% of patients indicating that
they would refer a friend or relative for a similar procedure.7
A study of patellar tendon fenestration demonstrated that
in 47 patellar tendons in 32 patients, 81% had an excellent
or good satisfaction score.19 Assessment of fenestration of
other tendons about the body has not been extensively
evaluated. One prior study described fenestration of the
J Ultrasound Med 2015; 34:2029–2035 2033
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Figure 4. Images from a 62-year-old man with tensor fascia latae tendi-
nosis and fenestration. A, Sonogram in a long-axis orientation to the ten-
sor fascia latae showing abnormal hypoechoic enlargement of the
proximal tensor fascia latae tendon (arrows) at the ilium (I). B, Twenty-
gauge needle (arrowheads) during fenestration (left side of image is
cephalad).
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gluteus medius and hamstring in 2 patients; however, a
more extensive evaluation of the hip and pelvis tendons
has not been completed.6 The results of our study show
that ultrasound-guided fenestration of 22 tendons about
the hip and pelvis resulted in marked improvement in 45.5%
and some improvement in 36.4%. A more long-term
follow-up assessment using clinic notes (average of 42
months after fenestration) showed that none of the patients
had worsening symptoms described in clinical notes beyond
the initial assessment. On the contrary, only 3 of the 21
patients had continued symptoms, with the others either
being asymptomatic or not discussing their symptoms
during routine follow-up clinic visits.
The gluteus medius was the most commonly treated
tendon in this study, representing 50% of our patients, with
most showing tendinosis. This finding is consistent 
with reports in the literature that the gluteus medius is com-
monly abnormal, with greater trochanteric pain syn-
drome.10,20 Of note, none of the patients in our study
group had bursal distention in the region of the greater
trochanter, a finding that is also consistent with prior stud-
ies indicating that bursal distention and true bursitis are
uncommon findings in greater trochanteric pain syn-
drome.20,21 The next most common tendon treated was
the proximal hamstring. In 2 of our patients, calcification
was present in the area of tendinosis. When evaluating the
specific tendon and fenestration outcomes, we found no
trend to indicate that fenestration of one tendon was
more likely to be successful than fenestration of another
tendon. In our study, only 9.1% of patients (2 of 22) had a
negative outcome (1 gluteus medius and 1 proximal ham-
string). There were no clinical variables (patient age, sex,
specific tendon, chronicity of symptoms, prior physical
therapy, or prior corticosteroid injection) or ultrasound
findings (tendinosis versus partial tear) that were signifi-
cantly different between the group that did not have a pos-
itive outcome and the group that responded favorably.
Although other ultrasound variables, such as the extent of
the tendon abnormality and flow on color or power
Doppler imaging, were not assessed in this study, a prior
study by Kanaan et al22 has shown that the only ultrasound
finding that was a positive predictive finding for successful
ultrasound-guided tendon fenestration was a well-defined
tendon abnormality; the presence or absence of hyperemia
on Doppler imaging was not a predictive finding.
Further types of percutaneous tendon treatments
have been described, such as injection of a hyperosmolar
dextrose solution, autologous whole blood, and platelet-
rich plasma.4 Of note, tendon fenestration is typically per-
formed with each of these other percutaneous tendon
treatments. Although a comprehensive review of these ten-
don treatments is not relevant to this study, it is important
to briefly review the studies in which tendon fenestration
alone has been compared to other percutaneous treatments.
A study by Dragoo et al23 comparing ultrasound-guided
fenestration to platelet-rich plasma for treatment of patel-
lar tendinopathy showed no significant difference in clin-
ical outcomes at 26 weeks after treatment. In addition,
studies comparing platelet-rich plasma to intratendon
saline injection for treatment of tendinopathy of the
common extensor tendon and Achilles tendon each
showed no significant differences in clinical outcomes.24,25
Further studies are still required to determine whether
fenestration alone is adequate for treatment of chronic
tendinopathy and if one treatment versus another is more
appropriate for tendinosis versus tendinosis with a super-
imposed tendon tear.
We acknowledge several imitations to this study.
Given the retrospective nature, we had to rely on dictated
follow-up visit notes from the referring clinicians to deter-
mine whether symptoms had improved. A prospective trial
would allow more specific and objective assessment of
patient symptoms at uniform intervals. In addition, imaging
follow-up was not obtained, so it is unclear whether changes
on ultrasound imaging occurred after the tendon fenestra-
tion and whether such changes correlated with patient out-
comes. Last, we did not compare tendon fenestration to
other treatments; a blinded randomized controlled trial
would be important to provide such information.
In conclusion, the results of our study show that ultra-
sound-guided tendon fenestration can be effective in the
treatment of tendinopathy about the hip and pelvis, show-
ing clinical improvement in 82%. Further studies are
required to determine the long-term effects of ultrasound-
guided tendon fenestration and to compare fenestration
to other percutaneous tendon treatments.
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